The Diagnosis of Polycystic Ovary Syndrome: The Criteria Are Insufficiently Robust for Clinical Research

    August 2007 in “ Clinical Endocrinology
    Julian H. Barth, Ephia Yasmin, Adam Balen
    Image of study
    TLDR The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.
    In the 2007 review, the authors criticized the diagnostic criteria for polycystic ovary syndrome (PCOS) as being insufficiently robust for clinical research. They pointed out the high phenotypic variability of PCOS, the low positive predictive value of single luteinizing hormone measurements, and the lack of a clear definition for hyperandrogenemia. The review also noted significant bias and variability in the assessment of anovulation and ovarian imaging, with inter-observer agreement as low as 51% for ultrasound imaging. The authors proposed new criteria for diagnosing PCOS, including validated scoring systems for clinical hyperandrogenism, specific protocols for blood sample analysis, cited methods for progesterone measurement, and consideration of insulin sensitivity. They concluded that the current diagnostic strategies were too vague, leading to potential misdiagnosis and hindering research into PCOS.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    4 / 4 results